Long-term experience with mycophenolate mofetilin liver transplantation for HCV-related cirrhosis.

被引：0
|
作者：
Avolio, A. W.
Agnes, S.
Siciliano, M.
Nure, E.
Grillo, R.
Barbarino, R.
Pompili, M.
Frongillo, F.
Pepe, G.
Castagneto, M.
机构：
[1] Catholic Univ Policlin A Gemelli, Transplantat Serv, Rome, Italy
[2] Catholic Univ Policlin A Gemelli, Microbiol Serv, Rome, Italy
来源：
LIVER TRANSPLANTATION | 2006年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：C83 / C83
页数：1
相关论文
共 50 条
  • [21] TYPE 2 DIABETES REDUCES OVERALL SURVIVAL AND INCREASES THE RISK OF HEPATIC DECOMPENSATION IN HCV-RELATED LIVER CIRRHOSIS. RESULTS FROM A PROSPECTIVE LONG-TERM STUDY DURING 8 YEARS
    Vilar-Gomez, E.
    Calzadilla Bertot, L.
    Yasells Garcia, A.
    Martinez Perez, Y.
    Romero-Gomez, M.
    Diago, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S346 - S346
  • [22] Results of liver transplantation for HCV cirrhosis. Tacrolimus based immunosuppression
    Pacholczyk, Marek
    Lagiewska, Beata
    Adadynski, Leszek
    Gontarczyk, Gajusz
    Lisik, Wojciech
    Perkowska-Ptasinska, Agnieszka
    Cieciura, Tomasz
    Wasiak, Dariusz
    Chmura, Andrzej
    TRANSPLANT INTERNATIONAL, 2007, 20 : 281 - 281
  • [23] CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis
    Giovanelli, S
    D'Errico, A
    Grazi, GL
    Lodato, F
    Colecchia, A
    Tame, MR
    Azzaroli, F
    Vetrone, G
    Del Gaudio, M
    Roda, E
    Mazzella, G
    JOURNAL OF HEPATOLOGY, 2004, 40 : 45 - 46
  • [24] Racial differences in outcome of liver transplantation in patients with HCV cirrhosis.
    Regev, A
    Reddy, RK
    Torres, MB
    Condero, RA
    Molina, EG
    Pyrsopoulos, NT
    Neff, GW
    Jeffers, LJ
    Tzakis, AG
    Schiff, ER
    HEPATOLOGY, 2000, 32 (04) : 259A - 259A
  • [25] Outcome after orthotopic liver transplantation in patients with HCV cirrhosis.
    Paik, SW
    Klein, A
    Boitnott, J
    Thuluvath, PJ
    GASTROENTEROLOGY, 1998, 114 (04) : A1319 - A1319
  • [26] Thl/Th2 serum cytokines imbalance and their relevance to severity of disease in HCV-related liver cirrhosis.
    Hady, AAA
    Desoky, AM
    El Damarawi, M
    Hammam, OA
    Sadek, A
    Hady, AMA
    CLINICAL CHEMISTRY, 2003, 49 (06) : A135 - A135
  • [27] AST/ALT ratio has prognostic value and is correlated to the MELD score in patients with HCV-related liver cirrhosis.
    Giannini, E
    Botta, F
    Fumagalli, A
    Malfatti, F
    Romagnoli, P
    Testa, E
    Chiarbonello, B
    Polegato, S
    Podesta, E
    Testa, R
    GASTROENTEROLOGY, 2002, 123 (01) : 48 - 48
  • [28] Familial clustering of HCV-related liver cirrhosis and hepatocellular carcinoma
    Pasta, L
    Marrone, C
    D'amico, M
    Bevacqua, EA
    D'Amico, G
    Pagliaro, L
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (09) : 716 - 717
  • [29] Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation.
    Berenguer, M
    Prieto, M
    Mora, J
    Rayon, M
    Carrasco, D
    San-Juan, F
    Burgueno, MD
    Pastor, M
    Ortiz, V
    Mir, J
    Berenguer, J
    HEPATOLOGY, 2000, 32 (04) : 259A - 259A
  • [30] The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis
    Papatheodoridis, GV
    Davies, S
    Dhillon, AP
    Teixeira, R
    Goulis, J
    Davidson, B
    Rolles, K
    Dusheiko, G
    Burroughs, AK
    TRANSPLANTATION, 2001, 72 (03) : 412 - 418
12345